GE Healthcare Technologies Inc
NASDAQ:GEHC

Watchlist Manager
GE Healthcare Technologies Inc Logo
GE Healthcare Technologies Inc
NASDAQ:GEHC
Watchlist
Price: 73.11 USD -0.4% Market Closed
Market Cap: 33.5B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one GEHC stock under the Base Case scenario is 105.12 USD. Compared to the current market price of 73.11 USD, GE Healthcare Technologies Inc is Undervalued by 30%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GEHC Relative Value
Base Case
105.12 USD
Undervaluation 30%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.7
P/S
P/S
Price to Sales
1.7
vs History
62
vs Industry
48
Median 3Y
1.8
Median 5Y
1.8
Industry
2.2
Forward
1.6
More Details
15.3
P/E
P/E
Price to Earnings
15.3
vs History
84
vs Industry
29
Median 3Y
20.2
Median 5Y
20.2
Industry
22.1
Forward
17.7
More Details
18.8
P/OCF
P/OCF
Price to OCF
18.8
vs History
28
vs Industry
21
Median 3Y
17.4
Median 5Y
17.4
Industry
13.9
More Details
88.3
P/FCFE
P/FCFE
Price to FCFE
88.3
vs History
15
vs Industry
8
Median 3Y
22
Median 5Y
22
Industry
19.7
More Details
3.6
P/B
P/B
Price to Book Value
3.6
vs History
81
vs Industry
18
Median 3Y
4.7
Median 5Y
4.7
Industry
2.1
More Details
1.9
EV/S
EV/S
Enterprise Value to Sales
1.9
vs History
81
vs Industry
46
Median 3Y
2.1
Median 5Y
2.1
Industry
2.4
Forward
1.8
More Details
4.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.5
vs History
87
vs Industry
42
Median 3Y
5.2
Median 5Y
5.2
Industry
4.9
More Details
11.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
11.5
vs History
78
vs Industry
26
Median 3Y
13
Median 5Y
13
Industry
11.6
Forward
10.9
More Details
13.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
13.9
vs History
84
vs Industry
28
Median 3Y
16.3
Median 5Y
16.3
Industry
15.7
Forward
13
More Details
21.2
EV/OCF
EV/OCF
Enterprise Value to OCF
21.2
vs History
31
vs Industry
18
Median 3Y
20.3
Median 5Y
20.3
Industry
13.9
More Details
27.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
27.5
vs History
21
vs Industry
17
Median 3Y
25.5
Median 5Y
25.5
Industry
17.3
More Details
1.4
EV/IC
EV/IC
Enterprise Value to IC
1.4
vs History
87
vs Industry
45
Median 3Y
1.6
Median 5Y
1.6
Industry
1.8
More Details

Multiples Across Competitors

GEHC Competitors Multiples
GE Healthcare Technologies Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
33.5B USD 1.7 15.3 11.5 13.9
US
Abbott Laboratories
NYSE:ABT
236.3B USD 5.6 17.5 22.7 32.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
183.9B USD 21.1 74.3 59.8 72.7
US
Boston Scientific Corp
NYSE:BSX
145.8B USD 8.3 71.7 33.9 47.2
US
Stryker Corp
NYSE:SYK
145.4B USD 6.3 50.9 25.2 30.3
IE
Medtronic PLC
NYSE:MDT
113.4B USD 3.4 24.3 13.6 19.4
DE
Siemens Healthineers AG
XETRA:SHL
52.1B EUR 2.2 24.9 14 19.4
US
Becton Dickinson and Co
NYSE:BDX
50B USD 2.4 32.9 13.1 24.6
US
Edwards Lifesciences Corp
NYSE:EW
44.7B USD 8.1 10.7 24.4 26.9
US
IDEXX Laboratories Inc
NASDAQ:IDXX
42.5B USD 10.8 47.5 33.7 37.7
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
286.9B CNY 8.1 25.8 22.6 22.6

See Also

Summary
GEHC intrinsic value, competitors valuation, and company profile.
DCF Valuation
GEHC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GEHC stock valuation using valuation multiples.
Wall Street Estimates
GEHC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GEHC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 261,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.